SF3B1 and neoplasm: Studies have highlighted that primary tumours with SF3B1 mutations display alternative splicing in selected key genes in CLL [12], MDS [30], and uveal melanoma [13], and that this signature is conserved between cancer sites and is independent of the mutant amino acid [16].